ITGAV and neoplasm: High risk of tumor recurrence, according to the 2015 American Thyroid Association guidelines [28], was associated with higher ITGA3 expression, whereas higher expression of ITGA2 and ITGAV correlated with intermediate-risk (Figure 4E, Table 5).